Fapifirst

Fapifirst Tablet is a medicine that belongs to a class of medicines called antiviral medicines. Fapifirst Tablet is used for managing patients suffering from mild to moderate Covid-19 infection.

Fapifirst Tablet is best taken in mildly infected individuals than in those who have severe Covid-19 infection. This is because early use of antiviral medicines, such as Fapifirst Tablet, is seen to be more effective in treating Covid-19 infection. Delay in treatment only slows down the recovery process and worsens the existing symptoms such as breathing issues, cough, or fever. If left untreated, this viral infection may even lead to organ failure. Once tested positive for Covid-19, consult your doctor immediately.

Fapifirst Tablet should not be used for treating patients who are allergic to Fapifirst Tablet or any of its ingredients. Children should not be given Fapifirst Tablet. It should not be given to patients with severe kidney or liver disease too. Additionally, people who have any abnormal uric acid levels or are suffering from gout must inform their doctor before taking Fapifirst Tablet. If you are planning a baby, pregnant or breastfeeding, consult your doctor before starting treatment with Fapifirst Tablet to avoid any potential harm to your baby. Follow your doctor’s instructions carefully to get maximum benefit.

Fapifirst Tablet should be taken in the dose and duration advised by the doctor. It is taken orally (by mouth) and the recommended dose is 1,800 mg twice on day 1, followed by 800 mg twice daily up to day 14. Do not self medicate. Follow your doctor’s instructions carefully to get maximum benefit from Fapifirst Tablet.

Since the elderly often have compromised organ functions, Fapifirst Tablet should be given with care to them, alongside regular monitoring. Fapifirst Tablet has not been administered in children. However, some early experimental data suggests that Fapifirst Tablet may cause serious side effects in the younger age group. Therefore, this medicine should not be consumed by the elderly and children, unless advised by your doctor.

No, Fapifirst Tablet should not be used for treating Covid-19 infection in pregnant or breastfeeding women. Fapifirst Tablet is not considered safe to be used in pregnant or breastfeeding mothers as its use may cause harmful effects on the baby. If you are planning a baby, pregnant or breastfeeding, consult your doctor if you are tested positive for Covid-19 or even if you are suspected of Covid-19 infection. Your doctor will decide what is best for you depending on your condition.

Fapifirst Tablet inhibits replication (a process by which this virus multiplies) of the Covid-19 virus and stops the further spread of the infection. In this way the amount of virus in the human body decreases, thereby leading to faster recovery.

Fapifirst Tablet should be stored at a temperature not more than 30 degrees Celsius. Make sure to keep it away from the reach of children.

Yes. Fapifirst Tablet may be given to patients with comorbidities such as diabetes and hypertension, under medical supervision. Follow your doctor’s instructions carefully to get the maximum benefit.